Immune effector cells in SpA: What are the pathways?

Immune effector cells in SpA: What are the pathways?

Bibliografiske detaljer
Main Authors:	Bowness, P, Ridley, A, Chen, L, Shi, H, Zaarour, N, Yager, N, Simone, D, Hammitzsch, A, Al-Mossawi, M
Format:	Conference item
Udgivet:	Clinical and Experimental Rheumatology 2018

Lignende værker

BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
af: Hammitzsch, A, et al.
Udgivet: (2014)

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis
af: Al-Mossawi, M, et al.
Udgivet: (2013)

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.
af: Al-Mossawi, M, et al.
Udgivet: (2013)

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.
af: Chen, L, et al.
Udgivet: (2015)

CHARACTERIZING TYPE 17 IMMUNE RESPONSES IN ANKYLOSING SPONDYLITIS
af: Al-Mossawi, H, et al.
Udgivet: (2013)

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
af: Hammitzsch, A, et al.
Udgivet: (2018)

The link between HLA-B27 and SpA--new ideas on an old problem.
af: McHugh, K, et al.
Udgivet: (2012)

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates
af: Simone, D, et al.
Udgivet: (2021)

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates
af: Simone, D, et al.
Udgivet: (2021)

SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS
af: De Wit, J, et al.
Udgivet: (2014)

miR-10b-5p is a novel Th17 regulator present in Th17 cells from Ankylosing Spondylitis
af: Chen, L, et al.
Udgivet: (2017)

Unique trancriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis
af: Al-Mossawi, M, et al.
Udgivet: (2017)

Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid
af: Yager, N, et al.
Udgivet: (2021)

Lessons from epigenetics for SpA
af: Knight, J
Udgivet: (2018)

Current Challenges in Managing SpA
af: Georg Schett
Udgivet: (2024-01-01)

GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
af: Shi, H, et al.
Udgivet: (2020)

Progress in our understanding of the pathogenesis of ankylosing spondylitis
af: Simone, D, et al.
Udgivet: (2018)

Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis
af: M. H. Al-Mossawi, et al.
Udgivet: (2017-11-01)

Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid
af: Yager, N, et al.
Udgivet: (2021)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
af: Ridley, A, et al.
Udgivet: (2013)

The why, what, and how of the new FACT standards for immune effector cells
af: Marcela V. Maus, et al.
Udgivet: (2017-04-01)

Puccinia striiformis f. sp. tritici effectors in wheat immune responses
af: Nan Wu, et al.
Udgivet: (2022-11-01)

Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis
af: Ooms, A, et al.
Udgivet: (2023)

From the genetics of ankylosing spondylitis to new biology and drug target discovery
af: Zaarour, N, et al.
Udgivet: (2021)

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele
af: Al-Mossawi, H, et al.
Udgivet: (2019)

ASAS definition for sacroiliitis on MRI in SpA: applicable to children?
af: Nele Herregods, et al.
Udgivet: (2017-04-01)

Novel therapeutic targets in axial spondyloarthritis
af: Worth, C, et al.
Udgivet: (2018)

Pathogenic immune responses in Spondyloarthritis
af: Al-Mossawi, M
Udgivet: (2016)

Entheseal Involvement in Spondyloarthritis (SpA) and Gout: An Ultrasound Comparative Study
af: Lucio Ventura-Ríos, et al.
Udgivet: (2022-05-01)

Identification and characterization of Toxoplasma gondii effectors that modulate innate immune pathways
af: Yang, Ninghan
Udgivet: (2015)

Abstract 16 — Are We Treating-to-Target on Spondyloarthritis (SpA)? A One-Year Analysis from the Asia Pacific League of Associations for Rheumatology (APLAR) SpA Registry
af: Isaac Cheng, et al.
Udgivet: (2023-11-01)

Spa /
af: 204268 Arieff, Allison
Udgivet: (2005)

Genotypic effects of ankylosing spondylitis associated il7r polymorphisms are mediated through monocytes in inflammation
af: Al-Mossawi, H, et al.
Udgivet: (2018)

<title language="spa">Nutritional status of endurance athletes: what is the available information?
af: Júlia A D. Nogueira, et al.
Udgivet: (2005-01-01)

Knowledge of General Practitioner’s toward Spondyloarthritis (SpA): A Qualitative Study
af: Mirza Zaka Pratama, et al.
Udgivet: (2022-11-01)

Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis
af: Ridley, A, et al.
Udgivet: (2016)

Guards and decoys: RIPoptosome and inflammasome pathway regulators of bacterial effector-triggered immunity.
af: Haleema Sadia Malik, et al.
Udgivet: (2025-01-01)

Immune effector mechanisms of the nitric oxide pathway in malaria: cytotoxicity versus cytoprotection
af: Hossein Nahrevanian

Signaling pathways and effectors of aging
af: Siamak Tabibzadeh
Udgivet: (2020-10-01)

Natural and therapy-induced immune control of HIV-1
af: Yager, N
Udgivet: (2011)